Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
11/16/2000 | WO2000033825A3 Compositions and methods for amelioration of human female sexual dysfunction |
11/16/2000 | WO2000026224A3 Novel macrolide antibiotics |
11/16/2000 | WO2000020358A3 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
11/16/2000 | DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use |
11/16/2000 | DE10021266A1 Hergestellte Artikel mit Phosphodiesterase-Inhibitor Produced with Article phosphodiesterase inhibitor |
11/16/2000 | CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
11/16/2000 | CA2373442A1 14.beta.-h-sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments |
11/16/2000 | CA2373256A1 Use of soluble costimulatory molecules to enhance immune responses |
11/16/2000 | CA2372871A1 Novel nucleic acids and proteins with growth hormone activity |
11/16/2000 | CA2372815A1 Extracellular matrix and adhesion-associated proteins |
11/16/2000 | CA2372714A1 The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis |
11/16/2000 | CA2369333A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
11/16/2000 | CA2366201A1 Use of selective antagonists of the .alpha.1b-adrenergic receptor for improvement of sexual dysfunction |
11/15/2000 | EP1051179A2 Anti-estrogen plus progestin containing oral contraceptives |
11/15/2000 | EP1051173A1 Derivatives of 1,3,4-oxadiazolone |
11/15/2000 | EP1051167A1 Pharmaceutical uses of optically pure (-) -bupropion |
11/15/2000 | EP1051166A1 Pharmaceutical uses of optically pure (+) -bupropion |
11/15/2000 | CN1273121A Process for preparing medicine to cure amenorrhoea |
11/15/2000 | CN1058400C Reinforcing kidney and supporting yang medicine |
11/15/2000 | CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ |
11/15/2000 | CN1058389C Use of compound of benzo-thiophenes |
11/14/2000 | US6147119 Biphenyl compounds and use thereof as oestrogenic agents |
11/14/2000 | US6147112 Administering to treat sexual and vascular disorders and diabetes |
11/14/2000 | US6147109 Treating impotency; brain, cardiovascular, respiratory system and gastrointestinal disorders |
11/14/2000 | US6147082 Chalcones having antiproliferative activity |
11/14/2000 | US6146876 22025, a novel human cyclic nucleotide phosphodiesterase |
11/14/2000 | US6146659 Method of administering liposomal encapsulated taxane |
11/14/2000 | US6146633 Endogenous and exogenous proteins, and fragments are chemically modified outside the body of an animal so that when injected into the animal, they produce more antibodies against the unmodified protein unmodified protein alone |
11/09/2000 | WO2000066736A1 Growth factor homolog zvegf4 |
11/09/2000 | WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
11/09/2000 | WO2000066612A1 Androgen glycosides and androgenic activity thereof |
11/09/2000 | WO2000066592A1 Cyclic urea and cyclic amide derivatives |
11/09/2000 | WO2000066591A1 Cyclocarbamate and cyclic amide derivatives |
11/09/2000 | WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
11/09/2000 | WO2000066581A1 Cyanopyrroles as progesterone receptor agonists |
11/09/2000 | WO2000066574A1 2,1-benzisothiazoline 2,2-dioxides |
11/09/2000 | WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
11/09/2000 | WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators |
11/09/2000 | WO2000066570A1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
11/09/2000 | WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
11/09/2000 | WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
11/09/2000 | WO2000066556A1 Indoline derivatives as progesterone antagonists |
11/09/2000 | WO2000066555A1 Thio-oxindole derivatives |
11/09/2000 | WO2000066225A1 Contraceptive compositions containing cyclic carbamates and amide derivatives |
11/09/2000 | WO2000066175A2 Conjugates as therapies for cancer and prostate diseases |
11/09/2000 | WO2000066168A1 Compositions containing benzimidazolones and progestogens |
11/09/2000 | WO2000066167A1 Contraceptive compositions containing indoline derivatives and progestational agents |
11/09/2000 | WO2000066166A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof |
11/09/2000 | WO2000066165A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
11/09/2000 | WO2000066164A1 Contraceptive compositions containing antiprogestinic and progestinic |
11/09/2000 | WO2000066163A1 Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestationals |
11/09/2000 | WO2000066149A1 Medicines useful for treating disorders of regulation of body fatness and diseases related to disorders of leptin production |
11/09/2000 | WO2000066148A1 Novel proteins |
11/09/2000 | WO2000066129A2 Use of antiprogestagens in combined therapy |
11/09/2000 | WO2000066128A1 Method of enhancing insulin action |
11/09/2000 | WO2000066114A1 Treatment of female arousal disorder |
11/09/2000 | WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
11/09/2000 | WO2000066103A2 Contraceptive compositions containing cyclic urea and amide derivatives |
11/09/2000 | WO2000066099A2 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
11/09/2000 | WO2000066097A2 Use of nicorandil in treatment of sexual dysfunctions or for enhancement of sexual functions |
11/09/2000 | WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
11/09/2000 | WO2000066084A1 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
11/09/2000 | WO2000066083A1 Folic acid supplement |
11/09/2000 | WO2000066082A1 Anti-nausea compositions and methods |
11/09/2000 | WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
11/09/2000 | WO2000039095A3 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
11/09/2000 | WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
11/09/2000 | WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy |
11/09/2000 | WO2000003678A3 Subcutaneous medroxyprogesterone acetate for contraception |
11/09/2000 | CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv |
11/09/2000 | CA2372948A1 Method of enhancing insulin action |
11/09/2000 | CA2372923A1 Dna encoding snorf36a and snorf36b receptors |
11/09/2000 | CA2372773A1 Contraceptive compositions containing antiprogestinic and progestinic |
11/09/2000 | CA2372768A1 Contraceptive compositions containing cyclic urea and amide derivatives |
11/09/2000 | CA2372595A1 Contraceptive compositions containing indoline derivatives and progestational agents |
11/09/2000 | CA2372591A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof |
11/09/2000 | CA2372586A1 Contraceptive compositions containing 2,1-benzisothiazoline 2,2-dioxides and progestationals |
11/09/2000 | CA2372279A1 Compositions containing benzimidazolones and progestogens |
11/09/2000 | CA2372229A1 Folic acid supplement |
11/09/2000 | CA2372225A1 Anti-nausea compositions and methods |
11/09/2000 | CA2371758A1 2,1-benzisothiazoline 2,2-dioxides |
11/09/2000 | CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
11/09/2000 | CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators |
11/09/2000 | CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
11/09/2000 | CA2371642A1 Cyclic urea and cyclic amide derivatives |
11/09/2000 | CA2371638A1 Indoline derivatives as progesterone antagonists |
11/09/2000 | CA2371635A1 Use of antiprogestagens in combined therapy |
11/09/2000 | CA2371633A1 Thio-oxindole derivatives |
11/09/2000 | CA2371632A1 Cyclocarbamate and cyclic amide derivatives |
11/09/2000 | CA2371629A1 3,3-substituted indoline derivatives |
11/09/2000 | CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
11/09/2000 | CA2369077A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
11/09/2000 | CA2368801A1 Conjugates as therapies for cancer and prostate diseases |
11/09/2000 | CA2368779A1 Contraceptive compositions containing cyclic carbamates and amide derivatives |
11/09/2000 | CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
11/09/2000 | CA2365782A1 Treatment of female arousal disorder |
11/08/2000 | EP1049781A1 Human chemokine and its use for detection and treatment of breast disease |
11/08/2000 | EP1049770A1 Secreted proteins and polynucleotides encoding them |
11/08/2000 | EP1049699A1 Azolo triazines and pyrimidines |
11/08/2000 | EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |